• BTC $5,295.42 (-3.46%)
  • ETH $155.83 (-5.33%)
  • MARKET CAP $171B
  • ICOs 4,212

ARNA Panacea

ENDED 195 views
7.2
Total Rate

ARNA Panacea is a solution which provides to all interested participants in the cancer diagnosis market with a new way of accessing and interacting with the system for collecting and storing medical research data. By using ARNA tokens, their holders will be able to access services and medical research data storage system for use in professional medical purposes, and to raise funds to begin new researches.
General
Website: Visit
White paper: Read
ICO Time: 15 Dec, 2017 - 10 Feb, 2018
Country: Russia
Token Info
Ticker: ARNA
Platform: Ethereum
Token type: ERC20
Financial
ICO Price: 1 ARNA = 0.08 USD
Accepting: ETH
Soft cap: 1,000,000 USD
Hard cap: 40,000,000 USD
Social Media
  • 1

    2013

    ARNA Genomics was established

  • 2

    2014

    Seed round; Development of ARNA-Thermometr, a test for the presence of oncological diseases; “Know-how” objects formalization

  • 3

    2015

    Development of ARNA Breast Cancer — a high-precision test for early detection of breast cancer

  • 4

    2016

    Development of ARNA Colon Cancer; ARNA BC development is completed; Beginning of laboratory tests of ARNA BC; Submission of patent application No 1

  • 5

    2017

    End of laboratory tests of ARNA BC; Start of ARNA BC clinical research jointly with Sechenov University; Submission of application of Patent Cooperation Treaty No 1; Token Distribution Event

  • 6

    2018

    - Opening of the office and the 1st laboratory unit in the USA. - Submission of application of Patent Cooperation Treaty No 2 and 3. - Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA. - ARNA CC development is completed, starting laboratory research. - ARNA Panacea – launch of the beta version of blockchain-ecosystem, basic documentation for develop

  • 7

    2019

    - Using of ARNA Panacea’s blockchain ecosystem by interested market players (regulators, investors, users, etc.) - Start of development: ARNA Lung, ARNA Liver, ARNA Pancreas; - ARNA BC’s entry into the US market; - Clinical trials in China; - National phases: USA, China, India, EU, UK, Israel, Brazil; - Seed round B; - Receiving the first revenue.

Magomed Chatuev

Software architect and developer

Ilya Senechkin

PhD, Wageningen University, Netherlands

Sergey Chernyshev

Ph.D., molecular biotechnologist

Anatoliy Melnikov

scientific supervisor and creator of the ARNA BC test

Dmitry Kulish

Candidate of Biological Sciences

George Nikitin

COO, co-founder and blockchain platform ideologist

Egor Melnikov

Founder of the project, CEO

Sergey Dolgachev

Entrepreneur and co-owner

Put this code to your website

Width: 420px-Height: 210px
comments powered by Disqus
Hot and trending ICOs
This website is using cookies. More info.